372 related articles for article (PubMed ID: 31896084)
1. Blood-brain barrier disruption with low-intensity pulsed ultrasound for the treatment of pediatric brain tumors: a review and perspectives.
Beccaria K; Canney M; Bouchoux G; Puget S; Grill J; Carpentier A
Neurosurg Focus; 2020 Jan; 48(1):E10. PubMed ID: 31896084
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors.
Beccaria K; Canney M; Bouchoux G; Desseaux C; Grill J; Heimberger AB; Carpentier A
Cancer Lett; 2020 Jun; 479():13-22. PubMed ID: 32112904
[TBL] [Abstract][Full Text] [Related]
3. Temporary blood-brain barrier disruption by low intensity pulsed ultrasound increases carboplatin delivery and efficacy in preclinical models of glioblastoma.
Dréan A; Lemaire N; Bouchoux G; Goldwirt L; Canney M; Goli L; Bouzidi A; Schmitt C; Guehennec J; Verreault M; Sanson M; Delattre JY; Mokhtari K; Sottilini F; Carpentier A; Idbaih A
J Neurooncol; 2019 Aug; 144(1):33-41. PubMed ID: 31197598
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
5. Safety and Feasibility of Repeated and Transient Blood-Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma.
Idbaih A; Canney M; Belin L; Desseaux C; Vignot A; Bouchoux G; Asquier N; Law-Ye B; Leclercq D; Bissery A; De Rycke Y; Trosch C; Capelle L; Sanson M; Hoang-Xuan K; Dehais C; Houillier C; Laigle-Donadey F; Mathon B; André A; Lafon C; Chapelon JY; Delattre JY; Carpentier A
Clin Cancer Res; 2019 Jul; 25(13):3793-3801. PubMed ID: 30890548
[TBL] [Abstract][Full Text] [Related]
6. Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models.
Sabbagh A; Beccaria K; Ling X; Marisetty A; Ott M; Caruso H; Barton E; Kong LY; Fang D; Latha K; Zhang DY; Wei J; DeGroot J; Curran MA; Rao G; Hu J; Desseaux C; Bouchoux G; Canney M; Carpentier A; Heimberger AB
Clin Cancer Res; 2021 Aug; 27(15):4325-4337. PubMed ID: 34031054
[TBL] [Abstract][Full Text] [Related]
7. Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.
Beccaria K; Sabbagh A; de Groot J; Canney M; Carpentier A; Heimberger AB
J Neurooncol; 2021 Jan; 151(1):65-73. PubMed ID: 32112296
[TBL] [Abstract][Full Text] [Related]
8. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
9. Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery.
Alli S; Figueiredo CA; Golbourn B; Sabha N; Wu MY; Bondoc A; Luck A; Coluccia D; Maslink C; Smith C; Wurdak H; Hynynen K; O'Reilly M; Rutka JT
J Control Release; 2018 Jul; 281():29-41. PubMed ID: 29753957
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-mediated disruption of the blood tumor barrier for improved therapeutic delivery.
Arsiwala TA; Sprowls SA; Blethen KE; Adkins CE; Saralkar PA; Fladeland RA; Pentz W; Gabriele A; Kielkowski B; Mehta RI; Wang P; Carpenter JS; Ranjan M; Najib U; Rezai AR; Lockman PR
Neoplasia; 2021 Jul; 23(7):676-691. PubMed ID: 34139452
[TBL] [Abstract][Full Text] [Related]
11. Combined local blood-brain barrier opening and systemic methotrexate for the treatment of brain tumors.
Cooper I; Last D; Guez D; Sharabi S; Elhaik Goldman S; Lubitz I; Daniels D; Salomon S; Tamar G; Tamir T; Mardor R; Fridkin M; Shechter Y; Mardor Y
J Cereb Blood Flow Metab; 2015 Jun; 35(6):967-76. PubMed ID: 25669901
[TBL] [Abstract][Full Text] [Related]
12. Development of a human in vitro blood-brain tumor barrier model of diffuse intrinsic pontine glioma to better understand the chemoresistance.
Deligne C; Hachani J; Duban-Deweer S; Meignan S; Leblond P; Carcaboso AM; Sano Y; Shimizu F; Kanda T; Gosselet F; Dehouck MP; Mysiorek C
Fluids Barriers CNS; 2020 Jun; 17(1):37. PubMed ID: 32487241
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial of blood-brain barrier disruption by pulsed ultrasound.
Carpentier A; Canney M; Vignot A; Reina V; Beccaria K; Horodyckid C; Karachi C; Leclercq D; Lafon C; Chapelon JY; Capelle L; Cornu P; Sanson M; Hoang-Xuan K; Delattre JY; Idbaih A
Sci Transl Med; 2016 Jun; 8(343):343re2. PubMed ID: 27306666
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition in a brain metastasis model by antibody delivery using focused ultrasound-mediated blood-brain barrier disruption.
Kobus T; Zervantonakis IK; Zhang Y; McDannold NJ
J Control Release; 2016 Sep; 238():281-288. PubMed ID: 27496633
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-mediated Delivery of Paclitaxel for Glioma: A Comparative Study of Distribution, Toxicity, and Efficacy of Albumin-bound Versus Cremophor Formulations.
Zhang DY; Dmello C; Chen L; Arrieta VA; Gonzalez-Buendia E; Kane JR; Magnusson LP; Baran A; James CD; Horbinski C; Carpentier A; Desseaux C; Canney M; Muzzio M; Stupp R; Sonabend AM
Clin Cancer Res; 2020 Jan; 26(2):477-486. PubMed ID: 31831565
[TBL] [Abstract][Full Text] [Related]
16. Translation of focused ultrasound for blood-brain barrier opening in glioma.
Brighi C; Salimova E; de Veer M; Puttick S; Egan G
J Control Release; 2022 May; 345():443-463. PubMed ID: 35337938
[TBL] [Abstract][Full Text] [Related]
17. Safe long-term repeated disruption of the blood-brain barrier using an implantable ultrasound device: a multiparametric study in a primate model.
Horodyckid C; Canney M; Vignot A; Boisgard R; Drier A; Huberfeld G; François C; Prigent A; Santin MD; Adam C; Willer JC; Lafon C; Chapelon JY; Carpentier A
J Neurosurg; 2017 Apr; 126(4):1351-1361. PubMed ID: 27285538
[TBL] [Abstract][Full Text] [Related]
18. Enhanced therapeutic agent delivery through magnetic resonance imaging-monitored focused ultrasound blood-brain barrier disruption for brain tumor treatment: an overview of the current preclinical status.
Liu HL; Yang HW; Hua MY; Wei KC
Neurosurg Focus; 2012 Jan; 32(1):E4. PubMed ID: 22208897
[TBL] [Abstract][Full Text] [Related]
19. Effects of Low-Intensity Pulsed Ultrasound-Induced Blood-Brain Barrier Opening in P301S Mice Modeling Alzheimer's Disease Tauopathies.
Géraudie A; Riche M; Lestra T; Trotier A; Dupuis L; Mathon B; Carpentier A; Delatour B
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569786
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy Delivery Strategies to the Central Nervous System: neither Optional nor Superfluous.
Drapeau A; Fortin D
Curr Cancer Drug Targets; 2015; 15(9):752-68. PubMed ID: 26077730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
